IRIDEX’s Cyclo G6 laser system receives CE Mark approval for treatment of glaucoma
IRIDEX Corporation, a leading global provider of innovative laser systems, delivery devices and consumables in ophthalmology, today announced that it has received its CE Mark to commercialize across Europe its first laser system in its class designed solely for use in treating glaucoma and its symptoms.